Literature DB >> 19030484

Sensitivity of tests to assess improvement in ADHD symptomatology.

Natalie Grizenko1, Martin Lachance, Vincent Collard, Philippe Lageix, Chantal Baron, Leila Ben Amor, Marina Ter Stepanian, Valentin Mbekou, George Schwartz, Johanne Bellingham, Ridha Joober.   

Abstract

OBJECTIVE: To assess which measurements best predict improvement on ADHD symptomatology after medication is given.
METHODS: 147 children aged 6 to 12 years, diagnosed with ADHD, participated in a double-blind placebo controlled twoweek crossover trial of methylphenidate.
RESULTS: There were statistically significant differences on all measures between placebo and medication. Effect size for the overall group was 0.33 (CGI-P), 0.80 (CGI-T), 1.33 (CGI), 0.56 (CPT), 0.82 (RASS).
CONCLUSIONS: Acute behavioural response measures, where children are observed by clinicians (RASS and CGI), were overall more reliable than parent reports in detecting improvement on ADHD symptomatology. Teacher reports were also very important, especially in the 9 to 12 year old group.

Entities:  

Keywords:  Attention Deficit Hyperactive Disorder; medication response; methylphenidate

Year:  2004        PMID: 19030484      PMCID: PMC2538631     

Source DB:  PubMed          Journal:  Can Child Adolesc Psychiatr Rev        ISSN: 1716-9119


  12 in total

1.  NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses.

Authors:  D Shaffer; P Fisher; C P Lucas; M K Dulcan; M E Schwab-Stone
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-01       Impact factor: 8.829

2.  Revision and restandardization of the Conners Teacher Rating Scale (CTRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

3.  Inattention, hyperactivity and impulsiveness: their impact on academic achievement and progress.

Authors:  C Merrell; P B Tymms
Journal:  Br J Educ Psychol       Date:  2001-03

4.  Independent dimensions of hyperactivity and aggression: a validation with playroom observation data.

Authors:  R Milich; J Loney; S Landau
Journal:  J Abnorm Psychol       Date:  1982-06

5.  Double-blind versus open evaluations of stimulant drug response in children with attention-deficit hyperactivity disorder.

Authors:  J Sprafkin; K D Gadow
Journal:  J Child Adolesc Psychopharmacol       Date:  1996       Impact factor: 2.576

6.  Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.

Authors:  B Vitiello; J B Severe; L L Greenhill; L E Arnold; H B Abikoff; O G Bukstein; G R Elliott; L Hechtman; P S Jensen; S P Hinshaw; J S March; J H Newcorn; J M Swanson; D P Cantwell
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2001-02       Impact factor: 8.829

Review 7.  National Institutes of Health Consensus Development Conference Statement: diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)

Authors: 
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2000-02       Impact factor: 8.829

8.  The revised Conners' Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity.

Authors:  C K Conners; G Sitarenios; J D Parker; J N Epstein
Journal:  J Abnorm Child Psychol       Date:  1998-08

9.  DSM-IV field trials for attention deficit hyperactivity disorder in children and adolescents.

Authors:  B B Lahey; B Applegate; K McBurnett; J Biederman; L Greenhill; G W Hynd; R A Barkley; J Newcorn; P Jensen; J Richters
Journal:  Am J Psychiatry       Date:  1994-11       Impact factor: 18.112

10.  Use of the restricted academic task in ADHD dose-response relationships.

Authors:  M Fischer; R F Newby
Journal:  J Learn Disabil       Date:  1998 Nov-Dec
View more
  5 in total

1.  A randomized trial of edivoxetine in pediatric patients with attention-deficit/hyperactivity disorder.

Authors:  Daniel Y Lin; Christopher J Kratochvil; Wen Xu; Ling Jin; Deborah N D'Souza; William Kielbasa; Albert J Allen
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-05       Impact factor: 2.576

2.  The orphan receptor GPR88 controls impulsivity and is a risk factor for Attention-Deficit/Hyperactivity Disorder.

Authors:  Sami Ben Hamida; Sarojini M Sengupta; Ellie Clarke; Michael McNicholas; Eleonora Moroncini; Emmanuel Darcq; Marina Ter-Stepanian; Marie-Ève Fortier; Natalie Grizenko; Ridha Joober; Brigitte L Kieffer
Journal:  Mol Psychiatry       Date:  2022-09-08       Impact factor: 13.437

3.  Sensitivity of scales to evaluate change in symptomatology with psychostimulants in different ADHD subtypes.

Authors:  Natalie Grizenko; Ricardo M Rodrigues Pereira; Ridha Joober
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2013-05

4.  Subcortical volumetric alterations as potential predictors of methylphenidate treatment response in youth with attention-deficit/hyperactivity disorder.

Authors:  Ji-Sahn Kim; Kyung Hwa Lee; Chan-Sop Hwang; Jae-Won Kim
Journal:  J Psychiatry Neurosci       Date:  2022-01-13       Impact factor: 6.186

Review 5.  Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).

Authors:  Ole Jakob Storebø; Erica Ramstad; Helle B Krogh; Trine Danvad Nilausen; Maria Skoog; Mathilde Holmskov; Susanne Rosendal; Camilla Groth; Frederik L Magnusson; Carlos R Moreira-Maia; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Bente Forsbøl; Erik Simonsen; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2015-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.